PMID- 19083105 OWN - NLM STAT- MEDLINE DCOM- 20090915 LR - 20211020 IS - 1573-7225 (Electronic) IS - 0957-5243 (Print) IS - 0957-5243 (Linking) VI - 20 IP - 5 DP - 2009 Jul TI - Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers. PG - 681-90 LID - 10.1007/s10552-008-9281-z [doi] AB - OBJECTIVES: A history of type 2 diabetes is one of few consistent risk factors for pancreatic cancer. Potentially modifiable factors related to fasting insulin and glucose concentrations may influence pancreatic cancer risk. METHODS: Multiple linear regression models were used to identify anthropometric, clinical, behavioral, and dietary factors associated with fasting insulin and glucose in a subcohort of non-diabetics in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (n = 366). Hazards ratios (HRs) and 95% confidence intervals (CIs) were calculated among the larger cohort (n = 27,035). RESULTS: During follow-up (median 16.1 years), 305 participants developed pancreatic cancer. Fasting insulin and/or glucose were positively associated with body mass index (BMI), height, and dietary total and saturated fat and inversely associated with serum high-density lipoprotein cholesterol (HDL) and dietary available carbohydrates, sucrose, and alcohol. Comparing highest to lowest quintiles, total fat (HR = 1.54, 95% CI 1.05-2.25, p-trend = 0.01) and saturated fat (HR = 1.38, 95% CI 0.97-1.98, p-trend = 0.06) were positively associated and available carbohydrates (HR = 0.63, 95% CI 0.44-0.90, p-trend = 0.01), particularly sucrose (HR = 0.62, 95% CI 0.43-0.89, p-trend = 0.09), were inversely associated with risk of pancreatic cancer. BMI, HDL, height, and alcohol were not associated with pancreatic cancer risk. CONCLUSION: Dietary fat is associated with higher fasting insulin concentrations and may increase pancreatic cancer risk in smokers. FAU - Meinhold, Cari L AU - Meinhold CL AD - Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, 6120 Executive Blvd, Rockville, MD 20852, USA. meinholdc@mail.nih.gov FAU - Berrington de Gonzalez, Amy AU - Berrington de Gonzalez A FAU - Albanes, Demetrius AU - Albanes D FAU - Weinstein, Stephanie J AU - Weinstein SJ FAU - Taylor, Philip R AU - Taylor PR FAU - Virtamo, Jarmo AU - Virtamo J FAU - Stolzenberg-Solomon, Rachael Z AU - Stolzenberg-Solomon RZ LA - eng GR - N01 CN045165/CN/NCI NIH HHS/United States GR - N01RC37004/RC/CCR NIH HHS/United States GR - Z01 CP010195-01/ImNIH/Intramural NIH HHS/United States GR - N01-RC-45035/RC/CCR NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, N.I.H., Intramural DEP - 20081213 PL - Netherlands TA - Cancer Causes Control JT - Cancer causes & control : CCC JID - 9100846 RN - 0 (Blood Glucose) RN - 0 (Insulin) SB - IM MH - Blood Glucose/*metabolism MH - Double-Blind Method MH - Humans MH - Insulin/*blood MH - Insulin Resistance MH - Linear Models MH - Middle Aged MH - Pancreatic Neoplasms/*epidemiology MH - Smoking/*adverse effects PMC - PMC2718707 MID - NIHMS85885 EDAT- 2008/12/17 09:00 MHDA- 2009/09/16 06:00 PMCR- 2010/07/01 CRDT- 2008/12/17 09:00 PHST- 2008/08/20 00:00 [received] PHST- 2008/11/28 00:00 [accepted] PHST- 2008/12/17 09:00 [entrez] PHST- 2008/12/17 09:00 [pubmed] PHST- 2009/09/16 06:00 [medline] PHST- 2010/07/01 00:00 [pmc-release] AID - 10.1007/s10552-008-9281-z [doi] PST - ppublish SO - Cancer Causes Control. 2009 Jul;20(5):681-90. doi: 10.1007/s10552-008-9281-z. Epub 2008 Dec 13.